We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Last Days of the Early Bird Pricings for Biologics World China 2012
News

Last Days of the Early Bird Pricings for Biologics World China 2012

Last Days of the Early Bird Pricings for Biologics World China 2012
News

Last Days of the Early Bird Pricings for Biologics World China 2012

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Last Days of the Early Bird Pricings for Biologics World China 2012"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

In the last few weeks three major joint ventures have been announced between international pharma’s and Chinese pharma’s. Merck & Co. will be working with Simcere, Pfizer is partnering with Hisun while AstraZeneca will be working with WuXi Appatec to develop and commercialize MEDI5117, a biologic for rheumatoid arthritis.

Giving us an insight into both big pharma and China will be AstraZeneca’s head of the China Biologics Innovation Center Jaiwen Han at Biologics World China 2012.

Biologics World China 2012  will be held on 5-7 November 2012 at Radisson Blu Hotel Pudong Century Park in Shanghai, China.

Organizations that are already confirmed attending include:
•    3S Bio
•    Acertus Pharma LLC
•    Bayer Pharma
•    BD Bioscience
•    BeiGene
•    Beijing Mab-Works
•    Beijing Triprime Genetic Engineering Co. Ltd.
•    Boehringer Ingelheim
•    BravoBio
•    Bristol-Myers Squibb
•    China Biologic Products
•    Chinese-Taipei Biotechnology Service Association
•    Citibank
•    Gan&Lee Pharmaceuticals
•    Genor BioPharma
•    Huabei Organization New Drug Development Company
•    HUYA Bioscience International
•    Innovent Biologics
•    Jiangsu Simcere Pharmaceutical R&D Co. Ltd
•    June He Law Offices
•    King Lai
•    Merck & Co.
•    Merck Millipore
Be heard, be seen by China's biologics industry!

Limited sponsorship and exhibition opportunities

If you have technologies, services or consulting expertise to offer to China’s Biopharma industry, it's your opportunity to act now!

Sartorius Stedim Biotech, Merck Millipore, Boehringer Ingelheim, TAP Biosystems, King Lai and BD Bioscience are already on board to showcase their capabilities at Biologics World China 2012.

Don't be the one to miss out! This unique and targeted biologics platform will be your one stop solution to reach out to the booming Chinese biopharma market!

80% of the exhibition and sponsorship opportunities have been sold and only very few showcase opportunities left!

Advertisement